L. S. Weilemann

1.3k total citations
64 papers, 883 citations indexed

About

L. S. Weilemann is a scholar working on Emergency Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. S. Weilemann has authored 64 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Emergency Medicine, 17 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. S. Weilemann's work include Poisoning and overdose treatments (17 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Pesticide Exposure and Toxicity (5 papers). L. S. Weilemann is often cited by papers focused on Poisoning and overdose treatments (17 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Pesticide Exposure and Toxicity (5 papers). L. S. Weilemann collaborates with scholars based in Germany, Switzerland and Nigeria. L. S. Weilemann's co-authors include M.-A. von Mach, Thomas Münzel, Jürgen Burhenne, Felix Post, Claudia‐Martina Messow, Christoph Sinning, Michael Lauterbach, Ludwig Gutmann, R. Besser and Helmut Schinzel and has published in prestigious journals such as Neurology, Radiology and CHEST Journal.

In The Last Decade

L. S. Weilemann

59 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. S. Weilemann Germany 16 226 206 174 150 126 64 883
Suman Wason United States 22 168 0.7× 290 1.4× 132 0.8× 150 1.0× 60 0.5× 47 1.1k
Salim Satar Türkiye 17 211 0.9× 258 1.3× 121 0.7× 101 0.7× 86 0.7× 137 924
Thomas Kaleekal United States 15 208 0.9× 226 1.1× 128 0.7× 387 2.6× 51 0.4× 44 1.0k
Zerrin Defne Dündar Türkiye 16 217 1.0× 181 0.9× 110 0.6× 209 1.4× 80 0.6× 59 702
P. Barriot France 11 109 0.5× 415 2.0× 131 0.8× 74 0.5× 73 0.6× 22 897
İbrahim Ikızcelı Türkiye 17 124 0.5× 236 1.1× 85 0.5× 58 0.4× 53 0.4× 84 820
J. E. Thompson United States 15 347 1.5× 182 0.9× 352 2.0× 167 1.1× 148 1.2× 27 931
Muhammet Güven Türkiye 23 128 0.6× 232 1.1× 170 1.0× 276 1.8× 32 0.3× 74 1.5k
Afzal Azim India 18 191 0.8× 170 0.8× 279 1.6× 231 1.5× 49 0.4× 96 1.0k

Countries citing papers authored by L. S. Weilemann

Since Specialization
Citations

This map shows the geographic impact of L. S. Weilemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. S. Weilemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. S. Weilemann more than expected).

Fields of papers citing papers by L. S. Weilemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. S. Weilemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. S. Weilemann. The network helps show where L. S. Weilemann may publish in the future.

Co-authorship network of co-authors of L. S. Weilemann

This figure shows the co-authorship network connecting the top 25 collaborators of L. S. Weilemann. A scholar is included among the top collaborators of L. S. Weilemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. S. Weilemann. L. S. Weilemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weilemann, L. S.. (2013). Droge ist nicht gleich Droge. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 108(6). 484–490. 5 indexed citations
2.
Lauterbach, Michael, et al.. (2009). Microbiological studies on the role of anaerobic bacteria in community-acquired aspiration pneumonia.. Infection. 37(1). 13–17. 7 indexed citations
3.
Post, Felix, L. S. Weilemann, Claudia‐Martina Messow, Christoph Sinning, & Thomas Münzel. (2008). B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients*. Critical Care Medicine. 36(11). 3030–3037. 106 indexed citations
4.
Börner, Norbert, et al.. (2008). Die sonographische Gallenblasenwandverdickung und ihre diagnostische Bedeutung bei intensivpflichtigen Patienten. Ultraschall in der Medizin - European Journal of Ultrasound. 9(3). 106–110. 1 indexed citations
6.
Schinzel, Helmut, et al.. (2006). Anticoagulation with low‐molecular‐weight heparin (dalteparin) in plasmapheresis therapy: initial experience. Transfusion. 46(4). 624–629. 11 indexed citations
7.
Lauterbach, Michael, Georg Horstick, Tibor Kempf, et al.. (2006). Anti-Inflammatory Treatment with Standardized Human Serum Protein Solution Reduces Local and Systemic Inflammatory Response after Hemorrhagic Shock. European Surgical Research. 38(4). 399–406. 3 indexed citations
8.
Mach, M.-A. von, Maren Hermanns‐Clausen, Inga Koch, et al.. (2005). Experiences of a Poison Center Network with Renal Insufficiency in Acetaminophen Overdose: An Analysis of 17 Cases. Clinical Toxicology. 43(1). 31–37. 31 indexed citations
9.
Lauterbach, Michael, et al.. (2005). Epidemiology of Hydrogen Phosphide Exposures in Humans Reported to the Poison Center in Mainz, Germany, 1983–2003. Clinical Toxicology. 43(6). 575–581. 31 indexed citations
10.
Mach, M.-A. von, et al.. (2005). Systemische fibrinolytische Therapie mit Urokinase bei Zentralarterienverschluss der Netzhaut. DMW - Deutsche Medizinische Wochenschrift. 130(16). 1002–1006. 8 indexed citations
11.
Mach, M.-A. von, et al.. (2003). Differences in Pharmacokinetics and Pharmacodynamics of Insulin Lispro and Aspart in Healthy Volunteers. Experimental and Clinical Endocrinology & Diabetes. 110(8). 416–419. 35 indexed citations
12.
Mach, M.-A. von & L. S. Weilemann. (2002). Zunehmende Bedeutung von Antidepressiva bei suizidalen und parasuizidalen Intoxikationen. DMW - Deutsche Medizinische Wochenschrift. 127(40). 2053–2056. 10 indexed citations
13.
Weilemann, L. S.. (2000). Primäre und sekundäre Giftelimination. Der Internist. 41(10). 1071–1076. 5 indexed citations
14.
Häfner, G., et al.. (1997). D-Dimer, Thrombin-Antithrombin III-Komplex (TAT) und Prothrombinfragment 1+2 (PTF). Der Anaesthesist. 46(8). 689–696. 8 indexed citations
15.
Schild, H., et al.. (1992). Wertigkeit von Röntgenbefunden in der Verlaufskontrolle des Atemnotsyndroms des Erwachsenen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 157(9). 262–266. 1 indexed citations
16.
Häfner, G., et al.. (1992). The control of anti-coagulation in acute dialyses with sensitive laboratory parameters. Scandinavian Journal of Clinical and Laboratory Investigation. 52(4). 289–296. 11 indexed citations
17.
Börner, Nikolaus, et al.. (1991). Diagnostik von Pleuraergüssen und Atelektasen: Sonographie und Radiologie im Vergleich. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 154(2). 159–163. 15 indexed citations
18.
Häfner, G., L. S. Weilemann, W. Ehrenthal, et al.. (1991). Acute dialysis: PMN-elastase as a new parameter for controlling individual anticoagulation with low molecular weight heparin (Fragmin®). Intensive Care Medicine. 17(1). 52–56. 6 indexed citations
19.
Besser, R., Ludwig Gutmann, Ulrich Dillmann, L. S. Weilemann, & H. C. Hopf. (1989). End‐plate dysfunction in acute organophosphate intoxication. Neurology. 39(4). 561–561. 54 indexed citations
20.
Weilemann, L. S., et al.. (1984). The metabolic status of internal intensive care patients as indicated by 3-methylhistidine excretion and nitrogen balance. Clinical Nutrition. 3(2). 83–88. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026